发表于

This clinical practice guideline from the American College of cardiology (ACC) and American Heart Association (AHA) provides recommendations applicable to patients with or at risk of developing cardiovascular disease (CVD).

ACC / AHA guideline on the primary prevention of cardiovascular disease

en

College of Cardiology / American Heart Association Task Force on Clinical Practice Guidelines, 2019

This clinical practice guideline from the American College of cardiology (ACC) and American Heart Association (AHA) provides recommendations applicable to patients with or at risk of developing cardiovascular disease (CVD). The focus is on medical practice in the United States, but the guidelines also have global relevance.

The guideline discusses risk factors for CVD including lifestyle and diet, plus comorbid conditions such as diabetes and chronic kidney disease (CKD). Specifically related to point-of-care testing (POCT), it provides information on risk factor parameters that can be obtained via POCT, such as lipid panels (total cholesterol, low- and high-density lipoprotein and trigycerides) to guide treatment decisions, such as statin therapy. HbA1c and albumin-creatinine ratio (ACR) are also highlighted as risk assessment parameters for patients with diabetes at risk of CVD.

The guidelines can be accessed here.

COL-08880 10/2021

相关新闻

卡片